Synthesis and Characterization of Injectable Hydrogels with Varying Collagen–Chitosan–Thymosin β4 Composition for Myocardial Infarction Therapy
Source abstract
Abstract
Thirty percent of global mortalities are caused by cardiovascular disease, and 54% of the aforementioned amount is instigated by ischemic heart disease that triggered myocardial infarction. Myocardial infarction is due to blood flow cessation in certain coronary arteries that causes lack of oxygen (ischemia) and stimulates myocardial necrosis. One of the methods to treat myocardial infarction consists in injecting cells or active biomolecules and biomaterials into heart infarction locations. This study aimed to investigate the characteristics of a collagen–chitosan-based hydrogel with variations in its chitosan composition. The prepared hydrogels contained thymosin β4 (Tβ4), a 43-amino acid peptide with angiogenic and cardioprotective properties which can act as a bioactive molecule for the treatment of myocardial infarction. A morphological structure analysis showed that the hydrogels lacked interconnecting pores. All samples were not toxic on the basis of a cytotoxicity test. A histopathological anatomy test showed that the collagen–chitosan–thymosin β4 hydrogels could stimulate angiogenesis and epicardial heart cell migration, as demonstrated by the evaluation of the number of blood vessels and the infiltration extent of myofibroblasts.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Cellular Mechanics and Interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Biomedical Engineering Study Program, Department of Physics, Faculty of Science and Technology, Airlangga University, Surabaya 60115, East Java, Indonesia
Institute of Tropical Disease, Airlangga University, Surabaya 60115, East Java, Indonesia
Department of Clinical Pharmacy, Faculty of Pharmacy, Airlangga University, Surabaya 60286, East Java, Indonesia
References (28)
Show source-provided references
1. Marelli, T.M. (2008). Buku Saku Dokumentasi Keperawatan, EGC.
2. Universal definition of myocardial infarction10.1093/eurheartj/ehm355 ↗
3. Biomaterials in cardiac tissue engineering: Ten years of research survey10.1016/j.mser.2007.08.001 ↗
4. Hydrogel based injectable scaffolds for cardiac tissue regeneration10.1016/j.biotechadv.2013.12.010 ↗
5. Heart failure management: The present and the future10.1089/ars.2009.2488 ↗
6. Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges10.1016/j.actbio.2010.06.039 ↗
7. Myocardial regeneration: Roles of stem cells and hydrogels10.1016/j.addr.2011.02.007 ↗
8. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium10.1006/jmcc.2001.1491 ↗
9. Cardiomyocyte grafting for cardiac repair: Graft cell death and anti-death strategies10.1006/jmcc.2001.1367 ↗
10. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction10.1089/107632704323061762 ↗
11. Controlled release of thymosin beta4 using collagen-chitosan composite hydrogels promotes epicardial cell migration and angiogenesis10.1016/j.jconrel.2011.05.026 ↗
12. Boccaccini, A.R., and Harding, S.E. (2011). Tissue Engineering Approaches for Myocardial Bandage: Focus on Hydrogel Constructs. Myocardial Tissue Engineering, Springer.10.1007/978-3-642-18056-9 ↗
13. Antibacterial and antioxidative activity of O-amine functionalized chitosan10.1016/j.carbpol.2017.04.027 ↗
14. Micromolding of photocrosslinkable chitosan hydrogel for spheroid microarray and co-cultures10.1016/j.biomaterials.2006.05.044 ↗
15. A collagen-chitosan hydrogel for endothelial differentiation and angiogenesis10.1089/ten.tea.2009.0504 ↗
16. Thymosin beta4 induces the expression of vascular endothelial growth factor (VEGF) in a hypoxia-inducible factor (HIF)-1alpha-dependent manner10.1016/j.bbamcr.2010.07.005 ↗
17. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair10.1038/nature03000 ↗
18. Cell-responsive hydrogel for encapsulation of vascular cells10.1016/j.biomaterials.2009.04.057 ↗
19. Clinical applications of angiogenic growth factors and their inhibitors10.1038/70928 ↗
20. Cell delivery mechanisms for tissue repair10.1016/j.stem.2008.02.005 ↗
21. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization10.1038/nature05383 ↗
22. Thymosin beta4 facilitates epicardial neovascularization of the injured adult heart10.1111/j.1749-6632.2010.05478.x ↗
23. Hydrogels in controlled release formulations: Network design and mathematical modeling10.1016/j.addr.2006.09.004 ↗
24. Controlled release of rhBMP-2 from collagen minipellet and the relationship between release profile and ectopic bone formation10.1016/j.ijpharm.2004.01.040 ↗
25. Collagen and its interactions with chitosan: III. Some biological and mechanical properties10.1016/0142-9612(96)89663-3 ↗
26. Morphology Study by Using Scanning Electron Microscopy
27. Sittampalam, G., Coussens, N., Brimacombe, K., and Al, E. (2013). Cell Viability Assays. Assay Guidance Manual, National Center for Advancing Translational Sciences.
28. The ECVAM international validation study on in vitro tests for acute skin irritation: Report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test10.1177/026119290703500614 ↗